Growth Metrics

Ocugen (OCGN) Net Income Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 12.59%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -115.33%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -290.15%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 59.59%
7 Evaxion A 64.16 Bn 64.14 Bn - -73.01%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,228.66%
10 Ocugen 452.01 Mn 452.01 Mn - -23.30%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -23.30%
Dec 31, 2025 -29.73%
Sep 30, 2025 -44.41%
Jun 30, 2025 2.77%
Mar 31, 2025 -29.75%
Dec 31, 2024 -21.76%
Sep 30, 2024 -4.34%
Jun 30, 2024 35.11%
Mar 31, 2024 33.94%
Dec 31, 2023 47.47%
Sep 30, 2023 43.29%
Jun 30, 2023 -9.10%
Mar 31, 2023 5.23%
Dec 31, 2022 -50.46%
Sep 30, 2022 -103.83%
Jun 30, 2022 15.78%
Mar 31, 2022 -168.90%
Dec 31, 2021 -286.97%
Sep 30, 2021 -2.68%
Jun 30, 2021 -608.91%
Mar 31, 2021 -79.44%
Dec 31, 2020 12.26%
Sep 30, 2020 -198.42%
Jun 30, 2020 -39.55%
Mar 31, 2020 28.76%
Dec 31, 2019 32.93%
Sep 30, 2019 -3.16%
Jun 30, 2019 64.29%
Mar 31, 2019 8.59%
Dec 31, 2018 -6.48%
Sep 30, 2018 40.04%
Jun 30, 2018 -14.49%
Mar 31, 2018 10.88%
Dec 31, 2017 24.04%
Sep 30, 2017 15.16%
Jun 30, 2017 20.72%
Mar 31, 2017 13.28%
Dec 31, 2016 5.04%
Sep 30, 2016 17.04%
Jun 30, 2016 -4.86%
Mar 31, 2016 1.25%
Dec 31, 2015 -24.96%
Sep 30, 2015 46.11%
Jun 30, 2015 -26.77%
Mar 31, 2015 -53.39%